Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GlaxoSmithKline Pharmaceuticals Ltd.

Division of GlaxoSmithKline PLC

Latest From GlaxoSmithKline Pharmaceuticals Ltd.

Ranitidine Recall Dents GSK India, Which Mulls Plant Sale

GlaxoSmithKline India’s Vemgal plant, which entailed a large investment outlay, may be put on the block as part of a review of assets impacted by the recall of ranitidine over NDMA impurity concerns. The site, which has “all relevant approvals”, has not made commercial supplies yet.

India Commercial

India Pharma 2020: Trends That Can Change Business Tempo

Scrip delves into some key trends that could play out in 2020 to shape and impact Indian pharmaceutical firms. Keep an eye on opportunities in key markets like China and the US, and on private equity interest in “control deals” and trade margin-related tweaks on the Indian market.

Policy & Regulation India

Graft Trail: Top Level Indian Regulatory Official Arrested

The arrest of India's deputy drugs controller creates shock waves and indicates an intent to clamp down on graft at any level, say industry experts.

Regulation Legal Issues

New Indian Public Shareholding Proposal Stumps Pharma

A proposal to increase the minimum public shareholding in listed firms in India, if implemented, is expected to impact the subsidiaries of GlaxoSmithKline, Novartis and AstraZeneca in the country, as well as local firms like Cadila Healthcare. Some of the foreign firms may well consider delisting

Policy & Regulation India
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Hasit Joshipura, Chmn.
    S. Khanna, VP, Fin.
  • Contact Info
  • GlaxoSmithKline Pharmaceuticals Ltd.
    Phone: (91) 22-2495-9595
    Dr. Annie Besant Rd.